These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 6532065)

  • 1. [Analysis of serum proteins in patients with gastric cancer--with special reference to the blood of the nutrient artery and vein of tumor].
    Kihara K
    Igaku Kenkyu; 1984 May; 54(6):603-47. PubMed ID: 6532065
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum testosterone level in the peripheral vein and the perigastric draining vein of patients with gastric carcinoma.
    Inutsuka S; Kumashiro R; Maekawa T; Hirabayashi M; Naitoh H; Kamachi H
    Jpn J Clin Oncol; 1988 Dec; 18(4):357-62. PubMed ID: 3204684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acute-phase proteins in the diagnosis of the extent of the pathological process in stomach cancer].
    Aleshkin VA; Vashakmadze LA; Aleshkina TN; Stenina OI
    Sov Med; 1986; (2):25-9. PubMed ID: 2422767
    [No Abstract]   [Full Text] [Related]  

  • 4. Alterations of APC, c-met, and p53 genes in tumor tissue and serum of patients with gastric cancers.
    Wang JY; Hsieh JS; Chen CC; Tzou WS; Cheng TL; Chen FM; Huang TJ; Huang YS; Huang SY; Yang T; Lin SR
    J Surg Res; 2004 Aug; 120(2):242-8. PubMed ID: 15234219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disseminated tumor cells in the blood of patients with gastric cancer are an independent predictive marker of poor prognosis.
    Illert B; Fein M; Otto C; Cording F; Stehle D; Thiede A; Timmermann W
    Scand J Gastroenterol; 2005 Jul; 40(7):843-9. PubMed ID: 16109661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevation of serum hepatocyte growth factor concentration in patients with gastric cancer is mediated by production from tumor tissue.
    Beppu K; Uchiyama A; Morisaki T; Nakamura K; Noshiro H; Matsumoto K; Nakamura T; Tanaka M; Katano M
    Anticancer Res; 2000; 20(2B):1263-7. PubMed ID: 10810432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of gene promoter hypermethylation in the tumor and serum of patients with gastric carcinoma.
    Lee TL; Leung WK; Chan MW; Ng EK; Tong JH; Lo KW; Chung SC; Sung JJ; To KF
    Clin Cancer Res; 2002 Jun; 8(6):1761-6. PubMed ID: 12060614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential use of soluble CD44 in serum as indicator of tumor burden and metastasis in patients with gastric or colon cancer.
    Guo YJ; Liu G; Wang X; Jin D; Wu M; Ma J; Sy MS
    Cancer Res; 1994 Jan; 54(2):422-6. PubMed ID: 7506122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gastric cancer and serum proteins. Diagnostic application of serum protein immunoelectrophoretic pattern (author's transl)].
    Konishi K; Watanabe K; Mai M
    Rinsho Byori; 1974 Jan; 22(1):69-72. PubMed ID: 4858586
    [No Abstract]   [Full Text] [Related]  

  • 10. Detection of aberrant methylation as a tumor marker in serum of patients with gastric cancer.
    Ichikawa D; Koike H; Ikoma H; Ikoma D; Tani N; Otsuji E; Kitamura K; Yamagishi H
    Anticancer Res; 2004; 24(4):2477-81. PubMed ID: 15330201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum tumor necrosis factor in patients with gastric cancer.
    Wu CW; Chi CW; Hsieh MC; Chao MF; Lui WY; P'Eng FK
    Anticancer Res; 1998; 18(3A):1597-9. PubMed ID: 9673376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical significance and correlation between elevated serum TR6 and lympho-metastasis in gastric cancer].
    Wu YL; Yu JX; Shen HW; Han B; Gao SL
    Zhonghua Wai Ke Za Zhi; 2003 Dec; 41(12):928-31. PubMed ID: 14728836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Significance of detecting disseminated tumor cells in peripheral blood of gastric and colorectal cancer patients].
    Zhang XW; Fan P; Yang HY; Yang L; Chen GY
    Zhonghua Zhong Liu Za Zhi; 2003 Jan; 25(1):66-9. PubMed ID: 12678992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intravenous loading with isotonic solutions in patients with cancer of the stomach and ulcerous disease: effect of loading on the volume of circulating blood and the level of blood serum proteins].
    Marczyńska A; Adamczyk B; Ciećkiewicz J; Oszacki J
    Pol Przegl Chir; 1970 Nov; 42(11):1653-9. PubMed ID: 5497488
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical utility of CA 72-4 serum marker in the staging and immediate post-surgical management of gastric cancer patients.
    Spila A; Roselli M; Cosimelli M; Ferroni P; Cavaliere F; Arcuri R; Tedesco M; Carlini S; D'Alessandro R; Perri P; Casciani CU; Greiner JW; Schlom J; Guadagni F
    Anticancer Res; 1996; 16(4B):2241-7. PubMed ID: 8694550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulated expression of complement factor I: a potential suppressive protein for gastric cancer identified by serum proteome analysis.
    Liu W; Liu B; Xin L; Zhang Y; Chen X; Zhu Z; Lin Y
    Clin Chim Acta; 2007 Feb; 377(1-2):119-26. PubMed ID: 17067565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of transforming growth factor beta1 are significantly correlated with venous invasion in patients with gastric cancer.
    Lin Y; Kikuchi S; Obata Y; Yagyu K;
    J Gastroenterol Hepatol; 2006 Feb; 21(2):432-7. PubMed ID: 16509870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated levels of serum and plasma metalloproteinases in patients with gastric cancer.
    Endo K; Maehara Y; Baba H; Yamamoto M; Tomisaki S; Watanabe A; Kakeji Y; Sugimachi K
    Anticancer Res; 1997; 17(3C):2253-8. PubMed ID: 9216697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of serum P53 antibody in patients with gastric cancer.
    Shiota G; Ishida M; Noguchi N; Takano Y; Oyama K; Okubo M; Katayama S; Harada K; Hori K; Ashida K; Kishimoto Y; Hosoda A; Suou T; Ito H; Kawasaki H
    Res Commun Mol Pathol Pharmacol; 1998 Jan; 99(1):41-51. PubMed ID: 9523354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum endostatin levels in gastric cancer patients: correlation with clinicopathological parameters.
    Koç M; Göçmen E; Kiliç M; Ozbay M; Oktem M; Tez M
    Hepatogastroenterology; 2006; 53(70):616-8. PubMed ID: 16995474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.